GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
208 hedge funds and large institutions have $2.91B invested in Global Blood Therapeutics, Inc. in 2019 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 90 increasing their positions, 52 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
29% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 41
Holders
208
Holding in Top 10
6
Calls
$58.9M
Puts
$32.1M
Top Buyers
| 1 | +$34.3M | |
| 2 | +$23.6M | |
| 3 | +$23.6M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$19.5M |
| 5 |
AG
Artal Group
Luxembourg
|
+$17M |
Top Sellers
| 1 | -$88.9M | |
| 2 | -$20.4M | |
| 3 | -$15.8M | |
| 4 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$11.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$10.4M |